Purna Pharmaceuticals NV
Industry
- Biotechnology
- Pharmaceuticals
- OTC, Consumer
- Contract Manufacturing Organization
See more in Biomedtracker
Latest on Purna Pharmaceuticals NV
Generics Bulletin
• By Chloe Kent
Belgian value-added medicines firm Hyloris Pharmaceuticals SA has successfully raised €15.0m ($16.2m) from investors “new and existing, local and international,” through an equity offering by means
Generics Bulletin
• By Chloe Kent
Belgian value-added medicines company Hyloris Pharmaceuticals SA has outlined an ambitious growth strategy while announcing its financial and operational results for the full-year ending 31 December
Generics Bulletin
• By Dave Wallace
Belgian value-added medicines specialist Hyloris Pharmaceuticals has struck a deal worth up to €4.3m ($5.2m) with Purna Female Healthcare to develop an innovative “dual mode-of-action” treatment for